Joseph Pearlberg

Joseph Pearlberg

Director/Board Member at
Neomorph, Inc.

Net worth: 568 067 $ as of 30/05/2026

62 year
Health Technology
Consumer Services
Finance

Profile

Joseph Pearlberg is currently Director at Neomorph, Inc., Associate at The Broad Institute, Inc., and Vice President at Deerfield Management Co. LP (Private Equity) since 2017.
Former roles include Medical Director at Sanofi, Independent Director at Nuvalent, Inc. from 2021 to 2026, and Vice President-Clinical Development at Infinity Pharmaceuticals, Inc. from 2016 to 2017.
Education includes a doctorate from Harvard University conferred in 1994, an undergraduate degree from the University of Pennsylvania conferred in 1985, and a doctorate from The University of California, San Francisco conferred in 1999.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/06/2025 5,146 ( 0.01% ) 568 067 $ 30/05/2026

Joseph Pearlberg active positions

CompaniesPositionStart
Corporate Officer/Principal -
Director/Board Member -
Private Equity Investor 30/06/2017

Former positions of Joseph Pearlberg

CompaniesPositionEnd
NUVALENT, INC. Director/Board Member 15/06/2026
INFINITY PHARMACEUTICALS, INC. Corporate Officer/Principal 30/06/2017
SANOFI Chief Tech/Sci/R&D Officer -
See the detail of Joseph Pearlberg's experience

Training of Joseph Pearlberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Joseph Pearlberg